Clinical Trial Update: The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is assessing the safety and tolerability of LBS-007 in patients with relapsed or resistant acute leukemia and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• LBS-007

Snippet

Sponsor: Lin BioScience, Inc | Conditions: Relapsed or Resistant Acute Leukaemias | Phase 1, Phase 2 | Status: RECRUITING